In this episode of High on Healthy, host Richard Zwicky sits down with Myriam Barthes, co-founder and CEO of Journey Clinical, to explore how integrating psychedelic medicine with structured psychotherapy creates scalable, meaningful mental health treatment.
Barthes discusses the critical role of medical oversight, preparation, and integration windows in fostering neuroplasticity, helping patients sit with discomfort, and guiding them back to their authentic, creative lives.
Key takeaways
- Psychedelic treatment works best when the dosing session is paired with preparation and integration sessions with a therapist.
- Most change after treatment shows up as small ordinary shifts, not dramatic breakthroughs.
- Psychedelic experiences are meant to help people sit with discomfort and suppressed parts of themselves instead of running from them.
- The experience is better understood as remembering who you already were than becoming someone new.
- Therapists do well to avoid rushing to meaning, because the meaning of an experience can keep changing over years.
The big idea: Why Does Integration Matter After a Psychedelic Experience?
More conversations on Psychedelic-Assisted Therapy, Trauma and Healing
Read the full transcript
Richard Zwicky: Hi everyone, I'm Richard Zwicky with High on Healthy, the show where we know there's no one path to healthy, so we explore them all. And today, we're going to discuss not just what psychedelics can do, but what happens when we turn a psychedelic experience into scalable mental health treatment. And over the last few months, we've been talking about all sorts of different aspects around mental health. Of course, psychedelics AI being another, direct intervention by therapists, and also just family relations and experiences for veterans and the But one thing that's come up in a few of the discussions regarding psychedelic experiences is, and that's really hasn't been tackled in depth, is what actually changes in someone's life. And we have a lot of stories where people say they've recovered from different aspects and what happens to them along as that path. But what beyond that changes?
Myriam Barthes: Thank you for having me.
Richard Zwicky: And joining us today to discuss the question further is Miriam Baris who's the co-founder and CEO of Journey Clinical which is the largest psychedelic assisted psychotherapy platform in the United States. Welcome aboard the show Miriam. I may not have phrased that statement as well as I would have liked to. Maybe I should take notes and prepare some of them ahead of time better. But the thing is, a psychedelic experience is incredibly individual. It's intimate. It's hard to predict. We know that there are changes that come out of it. We know that people change their lives. But what about their perspective? Is it that it enhances the perspective they had before or is it shifts the perspective they have on the world
Myriam Barthes: I'm so glad that you're asking this question because I think it is a question on everyone's mind. People always wonder but how does this really work? And what we have seen at Journey Clinical and what we have learned over the years is and this is why we've created it in the way that we have is that what enables people to change is when you combine psychedelic medicine with psychotherapy and the way we see it is the following. We adrenic clinic will follow a protocol that is called preparation, dosing and integration. And you do preparation and integration with your therapist. And what that means is you before you even have a psychedelic experience you start to set your intentions and you discuss what are your motivation, why are you doing this? And through that process there is actually quite a lot that comes up. And the integration process is then the ability to create meaning out of shows up in dosing session and then integrates that into daily life. And I think what the psychedelic experience does the metaphor I like to take is when you're a child and you're learning a new instrument, you have the neural pathways to do that and so you can learn a new note on the piano or on the guitar and that comes easy. And during psychedelic experiences, what we call the neuroplasticity window is actually the period where our brain is more receptive to the ability to form new patterns and new habits through this process of insights. So we typically see people during dosing session who have insights and then there is a 72-hour window especially with ketamine assisted psychotherapy on the back of it where you can work through those insight with your psychotherapist and the change doesn't happen necessarily overnight. Sometimes they're breakthrough but sometimes it's the small ordinary and more often than not that's what it is. It's small ordinary things. So you wake up in the morning, you feel a little bit more energized. You maybe in the past want to eat a cookie and then you want to eat an apple. There's small little things that over time allow you to change your life. And it's a very beautiful process but it's also I think not magical in the sense that it requires people's involvement and desire to change their lives. Someone is only going to feel better if this is something that they want and that they're willing to put work and effort into it.
Richard Zwicky: And like everything else it's not an easy button on the table that you hit and you're able to resolve your issues. It just opens the door for you to be able to do so.
00:05:00
Myriam Barthes: And that's why I always talk about the pairing of the psychedelic dosing or the psychedelic journey, the psychedelic experience with psychotherapy because those two together can truly create meaningful relational change or emotional change or improve family relationship. Making you aware that you were in a job that you didn't love and that before that you might not have even realized that reality
Richard Zwicky: That's very true. Unfortunately, most people go through their lives never having taken the opportunity or had the opportunity sometimes to follow their passions. They may know what they are, but they never really were able to prioritize it. And that's a loss. And sometimes it takes opening these doors to give ourselves the imp impetus to go do those things. But there's a lot of excitement around psychedelics and justifiably so because the work that's come out of it has been absolutely phenomenal and there's different psychedelics for different purposes and we can go through those at any point but there's also a lot of misunderstanding about what psychedelic assisted psychotherapy really is and in the past every generation of psychiatric breakthroughs and mental health gains from lithium to SSSRI arrived with the same language of transformation that people are using today for psychedelics that this will transform your life. Now psychedelics claims are different but they're still in the same vein. What makes you confident that psychedelics truly are different than the things we've tried before? And what would make somebody who's hesitant admit that? Yeah, It is different.
Myriam Barthes: I think a couple of things. One, people need options. So, not all treatments work for all people, and that's something at this point that we know. And so, I believe that psychedelic treatments are one more options, and it's not going to be right for everybody. And there are of course benefits and risks associated with them. And so my belief is simply to give people more treatment options and see how it works for the way psychedelics work that is pretty unique and you'll often hear people talk about is that it's not here to reduce your symptoms. It actually in fact makes you sit with the discomfort. So those psychedelic experiences often allow people to see parts of themselves that are suppressed or repressed have been ignored. And instead of running away from this discomfort, it's sitting for a couple hours with that discomfort and with those parts of us that we want to ignore because, they're a little inconvenient or we don't really love them. And so what happens is this process of integrating parts of ourselves and that's why I talked about the psychotherapy before because then there is the work with the psychotherapy to help you integrate these parts into your daily lives. And what I often say is this language of transformation I think is helpful in some ways but also psychedelics don't show you someone new. This is typic this is who you are. This is who you already were. This is you remember that you love to paint, but you haven't painted in the last 15 years because you were very busy paying your bills and trying to survive. And what I like to say is it has to do a lot more with remembering who you are than actually transforming into someone new. And that's what's very beautiful is that there's no change. It's who you were the whole time.
Richard Zwicky: It takes down even your own internal barriers to self-expression where so many of us feel we have to conform. Yep.
Myriam Barthes: That's and you see people going through treatments first of course they either longer show symptoms of depression or PTSD or anxiety and then when they continue through the treatment you see their creative selves coming to life and remember to I don't know do they like to swim if you like to sing whatever it is that you love to do and that you would do in the most natural of ways is
00:10:00
Myriam Barthes: What tends to emerge over time?
Richard Zwicky: And you came to psychedelics how and what changed for you versus let's say regular talk therapy or other forms that people approach challenges with.
Myriam Barthes: I came through psychedelics after a car accident. And I had to first do physical therapy. So, a couple years of purely, helping my body recover and regaining range of mobility. And then I had trauma from the car accident. And it was very kind of panic attacks and feeling in situations that would feel quite ordinary. And so someone said, "You should try second." I said, "Okay, let's do it." why not? And after six sessions all of the symptoms just I worked with IAS mainly and
Richard Zwicky: Which psychedelics did you try?
Myriam Barthes: And through that what I remembered about myself was very much I worked in finance I worked in AI before AI was what it has become. I worked in management consulting and so I had developed these skills that are very helpful and I wanted to apply them to a mission that meant a lot for me and after healing and seeing so many people feel better. The mission really was how do we bring these medicines into mainstream mental health care so that you can go to your doctor and do psychedelic therapy just like you would do any other treatments and so that you would be also screened for it in the same way. And there's the same found There is the same. And so that has been the motivation and for us one thing that was quite important was to really help empower the clinicians because these are the people that would do the work that would are on the front lines.
Richard Zwicky: All right.
Myriam Barthes: And so we spent a lot of time the last four, five years empowering clinicians to offer these treatments in their own practice and then having patients being able to access them with insurance coverage in their local communities. And it's been very beautiful work.
Richard Zwicky: And that's a profound effect for you and you're trying to replicate it in a clinical setting. We've talked on the show about how there's differences in the profound experiences they have when they go to retreat versus when they work with a therapist locally, versus some who work with a guide who's not a professional but has still been leading people on journeys for years. In your clinics, what separates the people who transform from the people who just had a remarkable afternoon?
Myriam Barthes: Again because we do this model of psychedelic assisted psychotherapy as the care model. So you don't only have a dosing or journey experience. You first have to do these preparation session with psychotherapists and then do integration with session with psychotherapist. So we don't in our model that's simply like how care actually works. We do offer multiple what we call modalities meaning we do for example couples ketamine assisted psychotherapy or we do 101 ketamine assisted psychotherapy but we're very much and we tell this to people you need to want to be involved in your own therapeutic process to do this work with Journey Clinical. And that has been our ethos and our approach since the beginning.
Richard Zwicky: And when somebody's approaching you and coming to you as the patient, are they looking at it as the psychedelic Is it the therapy that and what goes on while they're using the psychedelic the treatment or is it the window that gets opened for the future and therapies that becomes more effective and becomes the treatment. So where in the path does the person actually feel that moment?
Myriam Barthes: I mean the treatment is the whole when we describe the treatment we say you will first have a medical clearance. So you'll see a medical professional who will let you eligible for this treatment or not then you will engage in preparation session with your psychotherapist.
00:15:00
Myriam Barthes: There's a number of criteria people go through medical history,
Richard Zwicky: For people who are wondering what makes them eligible or not
Myriam Barthes: Psychiatric history, family history, medication. And there are a number of medical reasons why someone would not be eligible that can have to do with respiratory issues or heart issues or even sometimes gluccom. So we have a number of indication based on medical history. There are also counter indication based on psychiatric history. So schizophrenia for example may not be appropriate with this treatment and there are more so medical psychiatric and then we also look for a support system because this work can make you quite sensitive at least temporarily and so we want to make sure that people can go home in a place that feels safe. So medical clearance and
Richard Zwicky: No. And the reason I ask is, a lot of people ask me about it, and I'm not a doctor, so I can't give them here's what you should follow or not. And I just tell them, go speak to a professional. But they often have the concern or the question and I know a few people they were taking depression medication and anxiety medication and when they're on those they shouldn't do general rule of thumb they shouldn't be taking a particular treatment but getting off the prescription to be able to take the treatment is incredibly physically hard and sometimes traditional medications for those conditions are
Myriam Barthes: So this is a great question and
Richard Zwicky: So addictive almost we could say in terms of how when you want to stop taking them the withdrawal you go through it almost precludes you getting there. How do you help somebody in that situation or is it just the doors closed? Right.
Myriam Barthes: Maybe for your audience we wrote a blog with our medical team on who is a good candidate for ketamine assisted psychotherapy and who's not that could be helpful resource and I will say it is on a casebyase case basis. Broad certain things are incompatible but then it's on a case by case basis. Ketamine does have a strong safety profile and in a lot of cases can accommodate certain types of SSRIs with ketamine. Again and this is actually very important. We can't make any broad statements about it. It has to be. Which molecule is it which interaction is it dealing with? And to your point like this is very much a medical question. It has to be assessed by the medical professional. And then as you said this can be a very difficult process. So if that were to be the case, the medical professional would need to see this patient frequently during that tapering off period. And then there is a question mark. After the treatment do you stay off? Do you taper back on? As we know, as you said it's a very difficult experiencing physically. So what we want to do is give as much medical support as possible to this person. In some cases this is not appropriate. In some other cases it might be yes and you can stay on your medication and in some other cases it might be yes and there's some counter indication. So all of the permutations are possible and this is why adrenic clinical in our model you have a dedicated care team you have a medical professional and you have a psychotherapist and they work in collaboration together to make sure that you are safe and held every step of the way.
Richard Zwicky: And for people who are considering, consulting their physician for that, some are trained and understand the dynamics and some just don't and they tend to be more conservative and say no to everything, right? And it's just like so many have said no to cannabis for treat for cancer patients yet it's proven to be incredibly beneficial. Certain other conditions. How do you know who's the right physician to speak to? Right.
Myriam Barthes: Like Journey Clinical, that's what we do. There are some companies that do care delivery for psychedelic medicine or for ketamine for sprovado and so those clinics have to train their medical team to assess eligibility I mean that's how you reduce risk right that's how you reduce risk for the patients is making sure that the people are eligible in some cases I know sometimes we ask for additional medical clearances so we'll ask
00:20:00
Myriam Barthes: Or I don't know a cardiology medical clearance but I would say interventional psychiatry clinics provid clinics ivketamine clinics journey clinical these are the companies that have trained medical team and usually what I have learned is doctors are also really good at saying I don't know here's Someone. To talk to. So sometimes and we do quite a lot of education events for that reason for patients and for clinicians actually for PCPs for OBGYNS because we know that these questions come up and we know that they're not always equipped to answer them and so we create these educational events and then we're able to answer people's questions. So I would say specialized clinics are the clinics that know that are trained I think that through psychotherapy you catch a lot of nuance, right?
Richard Zwicky: And your model is medical oversight plus psychotherapy. What does a catch that conventional medicine misses?
Myriam Barthes: You catch of course through the medical team you have all of the physical aspects of it
Richard Zwicky: Right? Mhm. What?
Myriam Barthes: But through psychotherapy you actually even see the small changes which is what this work is built on we'll talk about breakthrough but really it's built on the small compounding changes into daily life and I think with psychotherapy you see that I also think that psychotherapy is in some ways like mechanism of durability where you can not only have these profound experiences and insights and so I think the therapy allows what to unfold and I will say it is not linear I think that's one thing with psychedelic I guess it's a therapy. This is absolutely not a linear process. You often see people who feel worse before they feel better. You see people who feel great and then don't feel you see all of the combinations. And so I think through this model you are able to provide continuity of care and see how the patients evolve.
Richard Zwicky: And on that for some people the breakthrough happens very quickly. For others, like you said, it takes many sessions, but a session can dissolve the story somebody's told themselves about themselves for decades and it helps them remove the mask that everybody saw as opposed to who they are. What happens and how do you help the individual and do you have a practice specifically in place to help the individual who comes out the other side and the people around them their partners, their families, they still expect the old version and they don't know how to handle the true self that's emerged. H how do you help them build the bridge back to that community without sacrificing themselves?
Myriam Barthes: That's such a beautiful question and true that happens. And this is why we from the get-go, I said before, we make sure that people have a support system and that the therapist is actually connected to their support system because as you said, people can change. And so we want the family and the people who are close to be a part of that process, a part of that evolution. And knowing that the change is more constant. It's not one change. It's maybe people become a little bit more sensitive or a little bit more as we said before they want to paint. And so the family and we see it always when we host events people who come are often loved ones. When we host these educational events, we often see someone's spouse, someone's partner, someone's aunt, someone's cousin who and so the families and maybe it's quite specific to our model because it's with psychotherapy and it's kind of an overtime model. The families are involved in that progression.
00:25:00
Myriam Barthes: We talk about what it means. The therapist can in some cases talk to the family about what this means, etc. So, it's not a process that happens outside. It's very much integrated into their lives. I mean, simply because, you need three hours available and then you won't be able to take any meetings after. You want to come back into a relaxing environment. So exactly.
Richard Zwicky: The next day is a write off as well.
Myriam Barthes: So be just because of that we need to educate the families into this is what you'll be seeing and expecting. So it's not an abrupt change but they can see small changes.
Richard Zwicky: And they'll see small changes which actually also goes to a separate question. What does a good conventional therapist need to unlearn to do this work? Great.
Myriam Barthes: H I love this. This is such a good question I think because so much of this process is un unlearning for the patient for the therapist for everybody. This is about unlearning. This is about not believing as you said in our old identities in what we call our protection mechanism. All the things that have helped us survive and were very helpful and also are no longer serving you the patient. And one thing in particular that I have seen with therapists is the desire for meaning making comes very quickly. Absolutely. And with psychedelics the meaning can unfold over years. And the meaning can evolve. So something that you saw a shape and a color and a landscape and it meant something the day after when you revisit that experience maybe three years later it takes on an entirely new meaning. So I think for the therapist there is this element of not rushing to meaning making and really allowing the patients inner intelligence in some ways guide and so actually during dosing session there's no psychotherapy done it's and very much an inward experience the psychotherapy is before and after but it's a lot of the patient letting things emerge as they emerge and not try to rush to meaning making. I would say that's the biggest thing shift in the therapist's mind that I've seen. But this is a great question.
Richard Zwicky: And leading out of that a clinic is a setting and the setting is central to the outcome with an experience as part of a journey. What does a clinical room do to an experience that you can have that you wouldn't have in the living room or a forest?
Myriam Barthes: One could argue that everything is in the forest but exact.
Richard Zwicky: No, we're in the forest. We're finding our way through.
Myriam Barthes: As you said, set and setting is a very important part of the experience. And what there's a couple thing I would say. One is because you need to feel really safe. You need to feel really safe so that you can access parts of yourself that you typically don't. And the relationship with the therapist and the trust that is built is paramount to how your experience is going to go or really mostly how you will allow yourself to feel these old suppressed emotions. So the safety of the container is really important. The therapist is a big part of it. Music is also a very important part of the journey or the dosing experience. Their playlists or we also see then people need to be comfortable and need to be able to have a blanket if they're a little bit cold. Sometimes temperature can lay down on a sofa. The lighting is another part. Sometimes the bright light can feel a little bit intense. So we want to have the lighting that is dim. Those are kind of the main elements.
00:30:00
Myriam Barthes: We also see, some therapists after the experience because with ketamines psychotherapy, people fast for a couple hours prior.
Richard Zwicky: And the sudden setting is key to making somebody comfortable
Myriam Barthes: And so we see therapists have ginger tea and a little bit of bread or some nuts so that patients can eat something. So how do we create safety and comfort is the broader question of set and setting. And then we have all these elements to do that.
Richard Zwicky: Because if they go in comfortable they're more likely to have a good experience whereas people who are uncomfortable it tends to excel to heighten those sensitivities. Activities and creates barriers. But one of the aspects and just that keeps coming up on the show and it's the focus of my day-to-day work is measurements. It's analytics. It's how do we make the treatment of mental health more measurable which makes it more personal. One of the aspects that some you talked about ketamine and of course you went through Iawaska we've had a number of guests on who have dealt with ibo gain and people who use psilocybin and different aspects do you see psychedelic therapy being matched to the person's history and most importantly a lot of people when they're dealing with these things they're dealing with PTSD and trauma but often they're also expressed as attachment style issues and pattern issues Do you see it being a series of a different battery of treatments or is it really one treatment but it's just a different path through to resolution?
Myriam Barthes: A couple things that came to mind is you were talking one I think I was talking to a therapist who said underneath it all there's always trauma. So that's something that I've heard multiple times from therapists. And then what I see in terms of the landscape and how things will evolve, we were quite limited by really regulations, FDA approvals. So we could only work with ketamine and esetamine. And that's what's available in the market today. But as we progress, we do expect psilocybin comp 360 FDA approval most likely in Q4 this year. And there are another 100 clinical trials for psychedelic drugs that are in phase one two or three. We know the FDA issued u vouchers to companies to have faster review. After submission. And so I see this evolving into very much a matrix of various treatment options and depending on your specific history, body, reality, there is going to be one treatment that will work for you. I think this is what we're building towards. I don't believe that we're here today, but that's the opportunity that we have.
Richard Zwicky: I think it'll be fascinating to see how people construct customized treatment protocols that bridge different psychedelics and therapies into one because it's inevitable that there's going to be a lot of personalization in those journeys And for attachment issues there's one thing for relationship issues MDMA is often very strong for getting off opiates and the I gain incredible could wax on and on about the different ones and the reality is we'll know so much more with the regulations coming through and people being able to do the proper ongoing experiments into so many other aspects but we are unfortunately running out of time. Miriam, people want to learn more about Journey Clinical and your work. How can they reach you and how can they find out more?
Myriam Barthes: They can go to our website journeyclinical.com and they can email us or find a provider as well. We have a public directory of providers who have been trained and do this work in 30 states. So that's
00:35:00
Richard Zwicky: Wonderful.
Myriam Barthes: Where thank you so much
Richard Zwicky: Thank you so much for joining us today on High on Healthy Miriam. And thanks to everybody for listening. I'm Richard Zwicky with High on Healthy and we'll be back again with you shortly.
This transcript was generated automatically and lightly edited for readability.
